On CNBC’s “Halftime Report Final Trades,” Jon Najarian said there was “unusual activity” in Royal Caribbean Cruises Ltd (NYSE:RCL). “I bought that,” he added.
Joseph Terranova of Virtus Investment Partners chose Merck & Co., Inc. (NYSE:MRK), saying the stock is “finally getting a technical breakout.” Shares of Merck are at the “highest levels for the year,” Terranova stated. He recommended to “take advantage of the valuation discount that exists for the health care sector relative to the S&P.
